Eva W. Iepsen

1.2k total citations
16 papers, 916 citations indexed

About

Eva W. Iepsen is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Endocrine and Autonomic Systems. According to data from OpenAlex, Eva W. Iepsen has authored 16 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Endocrine and Autonomic Systems. Recurrent topics in Eva W. Iepsen's work include Diabetes Treatment and Management (8 papers), Regulation of Appetite and Obesity (6 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Eva W. Iepsen is often cited by papers focused on Diabetes Treatment and Management (8 papers), Regulation of Appetite and Obesity (6 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Eva W. Iepsen collaborates with scholars based in Denmark, Australia and Germany. Eva W. Iepsen's co-authors include Signe S. Torekov, Jens J. Holst, Sten Madsbad, J. Lundgren, Torben Hansen, Oluf Pedersen, Jens‐Erik Beck Jensen, Nicolai J. Wewer Albrechtsen, Bolette Hartmann and Philipp E. Geyer and has published in prestigious journals such as Circulation, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Eva W. Iepsen

16 papers receiving 906 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva W. Iepsen Denmark 13 346 342 283 195 183 16 916
Christoffer Martinussen Denmark 13 152 0.4× 348 1.0× 333 1.2× 396 2.0× 86 0.5× 30 732
Francesco Cremasco Italy 9 357 1.0× 726 2.1× 136 0.5× 296 1.5× 119 0.7× 13 948
Cameron W. Lush Canada 13 196 0.6× 268 0.8× 255 0.9× 204 1.0× 206 1.1× 16 864
Robert Haws United States 15 331 1.0× 136 0.4× 82 0.3× 116 0.6× 103 0.6× 33 785
Kohei Okita Japan 19 364 1.1× 448 1.3× 210 0.7× 455 2.3× 62 0.3× 42 1.1k
S. Strobel United States 15 276 0.8× 1.0k 3.0× 275 1.0× 677 3.5× 172 0.9× 16 1.4k
Valerio Podio Italy 17 307 0.9× 111 0.3× 147 0.5× 153 0.8× 126 0.7× 30 923
Gillian E. Walker Italy 16 231 0.7× 178 0.5× 335 1.2× 89 0.5× 267 1.5× 34 953
A. Wettergren Denmark 14 290 0.8× 931 2.7× 266 0.9× 664 3.4× 253 1.4× 18 1.5k
B Astruc France 9 84 0.2× 142 0.4× 141 0.5× 74 0.4× 267 1.5× 21 689

Countries citing papers authored by Eva W. Iepsen

Since Specialization
Citations

This map shows the geographic impact of Eva W. Iepsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva W. Iepsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva W. Iepsen more than expected).

Fields of papers citing papers by Eva W. Iepsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva W. Iepsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva W. Iepsen. The network helps show where Eva W. Iepsen may publish in the future.

Co-authorship network of co-authors of Eva W. Iepsen

This figure shows the co-authorship network connecting the top 25 collaborators of Eva W. Iepsen. A scholar is included among the top collaborators of Eva W. Iepsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva W. Iepsen. Eva W. Iepsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sun, Emily, Eva W. Iepsen, Amanda L. Lumsden, et al.. (2021). A Gut-Intrinsic Melanocortin Signaling Complex Augments L-Cell Secretion in Humans. Gastroenterology. 161(2). 536–547.e2. 11 indexed citations
2.
Iepsen, Eva W., Simon Veedfald, Sten Madsbad, et al.. (2020). GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case Report. Cell Reports Medicine. 1(1). 100006–100006. 29 indexed citations
3.
Iepsen, Eva W., Jinyi Zhang, Mette Hollensted, et al.. (2019). Adults with pathogenic MC4R mutations have increased final height and thereby increased bone mass. Journal of Bone and Mineral Metabolism. 38(1). 117–125. 9 indexed citations
4.
Iepsen, Eva W., Jinyi Zhang, Henrik S. Thomsen, et al.. (2018). Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist. Cell Metabolism. 28(1). 23–32.e3. 99 indexed citations
5.
Iepsen, Eva W., Nicolai J. Wewer Albrechtsen, Mathilde Svendstrup, et al.. (2017). Patients With Long-QT Syndrome Caused by Impaired hERG -Encoded K v 11.1 Potassium Channel Have Exaggerated Endocrine Pancreatic and Incretin Function Associated With Reactive Hypoglycemia. Circulation. 135(18). 1705–1719. 36 indexed citations
6.
Christensen, Bodil, Eva W. Iepsen, J. Lundgren, et al.. (2017). Instrumentalization of Eating Improves Weight Loss Maintenance in Obesity. Obesity Facts. 10(6). 633–647. 24 indexed citations
7.
Engelbrechtsen, Line, J. Lundgren, Nicolai J. Wewer Albrechtsen, et al.. (2017). Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB. Obesity Science & Practice. 3(4). 425–433. 26 indexed citations
8.
Iepsen, Eva W., Michael Christiansen, Claus Graff, et al.. (2017). Glucose ingestion causes cardiac repolarization disturbances in type 1 long QT syndrome patients and healthy subjects. Heart Rhythm. 14(8). 1165–1170. 10 indexed citations
9.
Iepsen, Eva W., J. Lundgren, Jens J. Holst, Sten Madsbad, & Signe S. Torekov. (2016). Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3–36. European Journal of Endocrinology. 174(6). 775–784. 76 indexed citations
10.
Iepsen, Eva W., J. Lundgren, Claus Graff, et al.. (2016). Major rapid weight loss induces changes in cardiac repolarization. Journal of Electrocardiology. 49(3). 467–472. 12 indexed citations
11.
Geyer, Philipp E., Nicolai J. Wewer Albrechtsen, Stefka Tyanova, et al.. (2016). Proteomics reveals the effects of sustained weight loss on the human plasma proteome. Molecular Systems Biology. 12(12). 901–901. 173 indexed citations
12.
Iepsen, Eva W., Signe S. Torekov, & Jens J. Holst. (2015). Liraglutide for Type 2 diabetes and obesity: a 2015 update. Expert Review of Cardiovascular Therapy. 13(7). 753–767. 73 indexed citations
13.
Iepsen, Eva W., J. Lundgren, Bolette Hartmann, et al.. (2015). GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women. The Journal of Clinical Endocrinology & Metabolism. 100(8). 2909–2917. 153 indexed citations
14.
Iepsen, Eva W., J. Lundgren, Carsten Dirksen, et al.. (2014). Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss. International Journal of Obesity. 39(5). 834–841. 90 indexed citations
15.
Iepsen, Eva W., Signe S. Torekov, & Jens J. Holst. (2014). Therapies for inter-relating diabetes and obesity – GLP-1 and obesity. Expert Opinion on Pharmacotherapy. 15(17). 2487–2500. 35 indexed citations
16.
Torekov, Signe S., Eva W. Iepsen, Michael Christiansen, et al.. (2013). KCNQ1 Long QT Syndrome Patients Have Hyperinsulinemia and Symptomatic Hypoglycemia. Diabetes. 63(4). 1315–1325. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christoffer Martinussen Breakdown of academic impact, for papers by Francesco Cremasco Breakdown of academic impact, for papers by Cameron W. Lush Breakdown of academic impact, for papers by Robert Haws Breakdown of academic impact, for papers by Kohei Okita Breakdown of academic impact, for papers by S. Strobel Breakdown of academic impact, for papers by Valerio Podio Breakdown of academic impact, for papers by Gillian E. Walker Breakdown of academic impact, for papers by A. Wettergren Breakdown of academic impact, for papers by B Astruc
Rankless by CCL
2026